Join
Live feed
·
INSIDERFilingvia Quantisnow
Actinium Pharmaceuticals Inc. (Delaware) logo

Director Nicholson, C. David was granted 62,800 shares, increasing direct ownership by 12,560% to 63,300 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ATNM (Actinium Pharmaceuticals Inc. (Delaware)) and more on Quantisnow.